Abstract: An object of this invention is to provide a composition for preventing and/or treating neurodegenerative diseases and cerebral infarction, and a composition for ameliorating learning disorders. Provided is a composition comprising a combination of a TRH analog and arundic acid.
Type:
Grant
Filed:
September 27, 2017
Date of Patent:
November 10, 2020
Assignee:
BRIVENTION PHARMACEUTICAL (SHANGHAI) INC.